PBA
IVA

Paradigm Biocapital Advisors’s Inventiva IVA Stock Holding History

Paradigm Biocapital Advisors’s Portfolio IVA Stock Details IVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.1M Hold
4,000,000
– – 0.28% 28
2026
Q1 		$22.2M Hold
4,000,000
– – 0.45% 31
2025
Q4 		$18.6M Buy
+4,000,000
New +$18.6M 0.47% 29

Other funds holding IVA

CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Paradigm Biocapital Advisors's IVA Position: Q2 2026 in Review

Paradigm Biocapital Advisors held its Inventiva (IVA) position steady in Q2 2026 at 4,000,000 shares worth $15.1M. The position accounts for 0.28% of the portfolio, ranked #28.

Paradigm Biocapital Advisors first reported a position in IVA in Q4 2025 and has held it in 3 quarters since. The position peaked at $22.2M in Q1 2026. 88 funds tracked by Wall St. Rank hold IVA as of Q2 2026.

  • Paradigm Biocapital Advisors held 4,000,000 shares of Inventiva worth $15.1M as of Q2 2026.
  • Paradigm Biocapital Advisors left its Inventiva share count unchanged in Q2 2026.
  • Inventiva made up 0.28% of Paradigm Biocapital Advisors's portfolio in Q2 2026, its #28 holding.
  • Paradigm Biocapital Advisors first reported a position in Inventiva in Q4 2025 and has held it in 3 quarters since.
  • Paradigm Biocapital Advisors's Inventiva position peaked at $22.2M in Q1 2026.
  • 88 funds tracked by Wall St. Rank held Inventiva as of Q2 2026.

Based on Paradigm Biocapital Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.